Cancer Screening

by Edited by A. B. Miller , J. Chamberlain , N. E. Day , M. Hakama , P. C. Prorok

• ISBN13: 9780521116947
• ISBN10: 0521116945
• Edition: Revised
• Format: Paperback
• Copyright: 2011-06-09
• Publisher: Cambridge University Press

Summary

Screening is regarded as a cost-effective and clinically useful approach for the early diagnosis of several malignancies, especially such common cancers as those of the breast and the cervix. This 1991 is a publication from the Project on evaluation of Screening for Cancer, organized by the International Union Against Cancer (UICC), one of the world's foremost agencies in the field of cancer epidemiology and control. It contains recommendations from the international authorities on cancers for which screening is used. Findings from studies in many countries are presented and evaluated, and methodological issues are also discussed. This is an influential and authoritative statement on the scope of cancer screening. It will be of interest to oncologists, epidemiologists and others in the public health field.

Table of Contents

Preface

Screening for Breast Cancer: State of the Art on Breast Cancer Screening:

Sensitivity and specificity of screening in the UK trial of early detection of breast cancer

Screening for breast cancer in Finland

The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumour characteristics

The Malmö mammographic screening trial

The Canadian national breast screening study

The USSR/Germany/WHO BSE study and global strategies for the control of breast cancer

A cost-effectiveness approach to breast cancer screening

Summary of the discussion on breast cancer screening

Screening for Colorectal Cancer: State of the Art on Screening for Colorectal Cancer:

Colon cancer control study: status and current issues

An update on the Nottingham trial of faecal occult blood screening and rescreening of 51 325 subject

Interim report on a randomised trial of screening for colorectal cancer with Hemoccult-II

Case-control evaluation of colorectal cancer screening in the Federal Republic of Germany

Summary of the discussion on colorectal cancer screening

Screening of Cancer for the Cervix: State of the Art on Screening for Cancer of the Cervix:

The natural history of cancer of the cervix, and the implications for screening policy

Effect of organized screening on the risk of cervical cancer in the Nordic countries

The organisation of cervical screening in England and Wales

Indications for colposcopy from a UK viewpoint

Screening for cervix cancer in developing countries

Summary of the discussion on screening for cancer of the cervix

Screening for Ovarian Cancer: State of the Art on Screening for Ovarian Cancer:

Tumour markers in screening for ovarian cancer

Phase I investigation for early diagnosis of ovarian carcinoma

what problems are to be expected in a larger screening programme?

Screening for ovarian cancer

Summary of the discussion on screening for ovarian cancer

Screening for Malignant Melanoma: State of the Art on Screening for Melanoma:

Screening and early diagnosis for melanoma in Australia and New Zealand

Screening for melanoma in the UK

Screening for melanoma/skin cancer in the United States

The dysplastic naevus syndrome: implications for screening

Summary of the discussion on screening for melanoma of the skin

Screening for Prostate Cancer: State of the Art on Screening for Prostate Cancer:

Issue in screening for prostate cancer

Available screening tests for prostate cancer

Evaluation of screening for prostate, lung and colorectal cancers :the PLC trial

Summary of the discussion on screening for cancer of the prostate

Screening for Neuroblastoma: State of the Art on Screening for Neuroblastoma:

Neuroblastoma: studies in Japan

Screening for neuroblastoma, background, preliminary experience in the North of England and proposals for an evaluative study

Summary of the discussion on screening for neuroblastoma

Screening for Stomach Cancer: State of the Art on Screening for Stomach Cancer:

Evaluation of mass screening programme for stomach cancer in Japan

Summary for the discussion of screening for stomach cancer

Screening for Nasopharyngeal Cancer: State of the Art on Screening for Nasopharyngeal Cancer:

Screening for nasopharyngeal carcinoma

Summary of the discussion on screening for nasopharyngeal cancer

Methodological Issues:

Surrogate measures in the design of breast screening trials

Recent developments in cancer screening modeling

Case-control studies of screening

Summary of the discussion on new approaches to the evaluation of screening

Table of Contents provided by Publisher. All Rights Reserved.